ArticleSleep & breathing = Schlaf & Atmung2025
Restorative effect of sequential 4-channel neuromuscular electrical stimulation in obstructive sleep apnea: a feasibility study.
Article in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundDysphagia and sleep apnea share a common pathophysiology in that they involve the genioglossus muscle, which is important for chewing and swallowing. Sequential 4-channel neuromuscular electrical stimulation (NMES) based on the normal sequences of the suprahyoid and infrahyoid muscles has been shown to induce effective contractions of the genioglossus, styloglossus, and hyoglossus muscles. These effects may benefit patients with obstructive sleep apnea (OSA). This study aimed to evaluate the feasibility, safety, and efficacy of sequential 4-channel NMES in OSA.
methodsThis prospective, single-center, pilot study enrolled patients aged 19-60 years with moderate to severe OSA. All participants performed home-based sequential 4-channel NMES for 60 min per session, 5 times a week, for 8 weeks during the daytime. Polysomnographic studies and clinical evaluations were conducted before and after the treatment. The primary outcome was the change in the Apnea-Hypopnea Index (AHI) from baseline. Secondary outcomes included polysomnography results such as the Oxygen Desaturation Index (ODI), snore events and percentage, saturation parameters, and the respiratory arousal index, as well as patient-reported outcomes including the Epworth Sleepiness Scale, the Korean version of the Pittsburgh Sleep Quality Index, Likert scales for satisfaction and discomfort, and the EQ-5D-5 L.
resultsA total of ten participants completed the intervention and the follow-up evaluation. Eight weeks after the application of sequential 4-channel NMES, mean AHI reduced from 28.5 to 27.6 events/h, ODI decreased from 23.1 to 20.5 events/h, and snore percentage decreased from 38.1 to 32.3%, although none of these changes reached statistical significance. The mean duration and percentage of sleep time with oxygen saturation < 90% in polysomnography decreased from 38.7 min to 12.9 min (3.4%), also without statistical significance. And patient-reported outcomes improved after treatment, but these changes were not statistically significant.
conclusionsThis study was the first to investigate sequential 4-channel NMES as a therapeutic option for patients with OSA. Given its feasibility and efficacy, 4-channel NMES warrants investigation in a larger, definitive trial in the future.
Indexed as
Identifiers
41014458What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.